M. Azure

发表

Imaging, biodistribution, and toxicology evaluation of (212)Pb-TCMC-trastuzumab in nonhuman primates.

T. Schoeb, D. Fisher, Benjamin B. Kasten, 2016, Nuclear medicine and biology.

Noninvasive Targeted Imaging of Matrix Metalloproteinase Activation in a Murine Model of Postinfarction Remodeling

D. Dione, A. Sinusas, L. Dobrucki, 2005, Circulation.

Survival of Cloudman mouse melanoma cells after irradiation by solar wavelengths of light.

D. Mitchell, R. Boissy, M. Meyenhofer, 1997, Pigment cell research.

Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients.

S. Shen, R. Meredith, E. Banaga, 2014, Cancer biotherapy & radiopharmaceuticals.

Molecular Imaging of Matrix Metalloproteinase Activation to Predict Murine Aneurysm Expansion In Vivo

A. Sinusas, L. Dobrucki, M. Sadeghi, 2010, Journal of Nuclear Medicine.

Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy.

N. Wong, N. Narula, P. Yalamanchili, 2008, Journal of the American College of Cardiology.

Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients

S. Shen, R. Meredith, E. Banaga, 2013 .

Effects of food intake and anesthetic on cardiac imaging and uptake of BMS747158-02 in comparison with FDG

S. Robinson, M. Azure, Mary Guaraldi, 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Evaluation of myocardial matrix metalloproteinase (MMP) mediated post-MI remodeling with a novel radiolabeled MMP inhibitor

A. Sinusas, L. Dobrucki, F. Spinale, 2004 .

Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.

L. Dinkelborg, C. Nelson, David M. Wilson, 2007, Journal of medicinal chemistry.

First in human alpha radioimmunotherapy with 212Pb-TCMC-trastuzumab

S. Shen, R. Alvarez, R. Meredith, 2013 .

Synthesis and Cardiac Imaging of (18)F-Ligands Selective for β1-Adrenoreceptors.

P. Yalamanchili, S. Robinson, T. Harris, 2011, ACS medicinal chemistry letters.

Evaluation of LMI1195, a Novel 18F-Labeled Cardiac Neuronal PET Imaging Agent, in Cells and Animal Models

S. Robinson, P. Yalamanchili, J. Lazewatsky, 2011, Circulation. Cardiovascular imaging.

αvβ3‐Targeted detection of arteriopathy in transplanted human coronary arteries: an autoradiographic study

A. Sinusas, B. Zaret, G. Tellides, 2005 .

The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts

K. Zinn, C. Nelson, M. Azure, 2014, The Journal of Nuclear Medicine.

Evaluation of LMI 1195 , a Novel 18 F-Labeled Cardiac Neuronal PET Imaging Agent , in Cells and Animal Models

S. Robinson, P. Yalamanchili, J. Lazewatsky, 2011 .

Abstract 1914: BMS753951: A Novel Low Molecular Weight Magnetic Resonance Contrast Agent Selective For Arterial Wall Imaging

S. Robinson, P. Yalamanchili, T. Harris, 2007 .

Cardiac imaging and uptake mechanism of 18F LMI1195, a novel PET cardiac neuronal imaging agent

P. Yalamanchili, S. Robinson, M. Azure, 2010 .

Cardiac retention of PET neuronal imaging agent LMI1195 in different species: impact of norepinephrine uptake-1 and -2 transporters.

S. Robinson, M. Azure, Mary Guaraldi, 2013, Nuclear medicine and biology.

Alphavbeta3-targeted detection of arteriopathy in transplanted human coronary arteries: an autoradiographic study.

A. Sinusas, B. Zaret, G. Tellides, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Synthesis and biological evaluation of pyridazinone analogues as potential cardiac positron emission tomography tracers.

S. Robinson, P. Yalamanchili, A. Purohit, 2008, Journal of medicinal chemistry.

Mechanism of uptake and retention of F-18 BMS-747 158-02 in cardiomyocytes: a novel PET myocardial imaging agent

S. Robinson, P. Yalamanchili, A. Purohit, 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Quinazoline derivatives as MC-I inhibitors: evaluation of myocardial uptake using Positron Emission Tomography in rat and non-human primate.

S. Robinson, A. Purohit, M. Azure, 2007, Bioorganic & medicinal chemistry letters.

Atherosclerosis Plaque Heterogeneity and Response to Therapy Detected by In Vivo Molecular Imaging of Matrix Metalloproteinase Activation

A. Sinusas, L. Dobrucki, S. Robinson, 2011, The Journal of Nuclear Medicine.

Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling

A. Sinusas, L. Dobrucki, M. Sadeghi, 2008, Circulation.

BMS-747 158-02: A novel PET myocardial perfusion imaging agent

Mary Guaraldi, Ming Yu, Mikhail Kagan, 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Molecular Imaging of Matrix Metalloproteinase Expression in Atherosclerotic Plaques of Mice Deficient in Apolipoprotein E or Low-Density-Lipoprotein Receptor

N. Narula, T. Murohara, J. Narula, 2009, Journal of Nuclear Medicine.

Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates

S. Robinson, P. Yalamanchili, A. Purohit, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Cardiac imaging and safety evaluation of BMS747158, a novel PET myocardial perfusion imaging agent, in chronic myocardial compromised rabbits

S. Robinson, M. Azure, Mary Guaraldi, 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Dosimetry of BMS747158, a novel 18F labeled tracer for myocardial perfusion imaging, in nonhuman primates at rest

S. Robinson, J. Lazewatsky, M. Azure, 2008 .

Synthesis and biological evaluation of the mitochondrial complex 1 inhibitor 2-[4-(4-fluorobutyl)benzylsulfanyl]-3-methylchromene-4-one as a potential cardiac positron emission tomography tracer.

S. Robinson, P. Yalamanchili, M. Azure, 2007, Journal of Medicinal Chemistry.

[18F](R)-5-chloro-1-(1-cyclopropyl-2-methoxyethyl)-3-(4-(2-fluoroethoxy)-2,5-dimethyl phenylamino)pyrazin-2(1H)-one: introduction of N3-phenylpyrazinones as potential CRF-R1 PET imaging agents.

Vijay T. Ahuja, J. Macor, T. Molski, 2012, Bioorganic & medicinal chemistry letters.

A MULTITHERAPY RESISTANCE FACTOR FROM MELANOMA REVEALS THAT KILLING BY NEAR UV IS DIFFERENT FROM GENOTOXIC AGENTS

R. Sayre, M. Azure, K. Cieszka, 1995, Photochemistry and photobiology.